IL230690A0 - Compositions and methods for treating myelodysplastic syndrome - Google Patents

Compositions and methods for treating myelodysplastic syndrome

Info

Publication number
IL230690A0
IL230690A0 IL230690A IL23069014A IL230690A0 IL 230690 A0 IL230690 A0 IL 230690A0 IL 230690 A IL230690 A IL 230690A IL 23069014 A IL23069014 A IL 23069014A IL 230690 A0 IL230690 A0 IL 230690A0
Authority
IL
Israel
Prior art keywords
compositions
methods
myelodysplastic syndrome
treating myelodysplastic
treating
Prior art date
Application number
IL230690A
Other languages
Hebrew (he)
Original Assignee
Telik Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Telik Inc filed Critical Telik Inc
Publication of IL230690A0 publication Critical patent/IL230690A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06Tripeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL230690A 2011-08-02 2014-01-28 Compositions and methods for treating myelodysplastic syndrome IL230690A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/046316 WO2013019220A1 (en) 2011-08-02 2011-08-02 Compositions and methods for treating myelodysplastic syndrome

Publications (1)

Publication Number Publication Date
IL230690A0 true IL230690A0 (en) 2014-03-31

Family

ID=44630579

Family Applications (1)

Application Number Title Priority Date Filing Date
IL230690A IL230690A0 (en) 2011-08-02 2014-01-28 Compositions and methods for treating myelodysplastic syndrome

Country Status (2)

Country Link
IL (1) IL230690A0 (en)
WO (1) WO2013019220A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4113611A (en) 1976-11-16 1978-09-12 Westinghouse Electric Corp. Magnetic pipe cleaner
US5599903A (en) 1992-04-03 1997-02-04 Terrapin Technologies, Inc. Glutathione analogs and paralog panels comprising glutathione mimics
US7029695B2 (en) 2001-07-10 2006-04-18 Telik, Inc. Therapeutic compositions containing glutathione analogs
US7511611B2 (en) 2006-05-18 2009-03-31 Casella Waste Systems, Inc. Systems for and methods of asset management in a waste management service environment
US10322522B2 (en) 2015-03-12 2019-06-18 Robert Bosch Tool Corporation Electrical configuration for object detection system in a saw

Also Published As

Publication number Publication date
WO2013019220A1 (en) 2013-02-07

Similar Documents

Publication Publication Date Title
HK1252940A1 (en) Methods and compositions for treating ineffective erythropoiesis
HK1214521A1 (en) Compositions and methods for treating proteinopathies
HK1201475A1 (en) Methods and compositions for treating pain
HK1251796A1 (en) Methods and compositions for treating diabetes
IL227429A0 (en) Compositions and methods for treating cancer
GB2494845B (en) Compositions and methods for treating automotive surfaces
EP2755482A4 (en) Compositions and methods for treating cancer
EP2684167A4 (en) Compositions and methods useful for treating diseases
HK1190936A1 (en) Methods and compositions for treating metabolic syndrome
ZA201404187B (en) Compositions and methods for treating dental conditions
HK1209633A1 (en) Compositions and methods for treating diabetes
ZA201307187B (en) Synergistic compositions and methods
HK1201469A1 (en) Compositions and methods for hemostasis
HK1206641A1 (en) Methods and compositions for treating inflammation
IL232648A0 (en) Compositions and methods for treating glioma
IL229231A0 (en) Compositions and methods for treating cancer
ZA201308892B (en) Compositions and methods
EP2766357A4 (en) Meso-biliverdin compositions and methods
EP2723346A4 (en) Compositions and methods useful for treating pediculosis
PL2392329T3 (en) Compositions for use in treating myelodysplastic syndrome
EP2718427A4 (en) Compositions and methods for glioblastoma treatment
IL230729A0 (en) Compositions and methods for treating myelodysplastic syndrome
IL230689A0 (en) Compositions and methods for treating myelodysplastic syndrome
IL230690A0 (en) Compositions and methods for treating myelodysplastic syndrome
EP2800763A4 (en) Compositions and methods for treating multiple sclerosis